Phio Pharmaceuticals Corp. (PHIO) Reports Material Event to SEC
Filing Details Phio Pharmaceuticals Corp. (NASDAQ:PHIO) filed a Form 8-K with the Securities and Exchange Commission on July 21, 2026, disclosing a material event. Market Context…
Read more
